Interventions for valvular disease
CT-Angiographic imaging of the Carillon device topography after unsuccessful treatment of FMR May 12, 2020 | 10.4244/EIJ-D-20-00332
Showing 1-20 of 62 articles
Coronary interventions
Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial February 7, 2020 | 10.4244/EIJ-D-18-01000
Coronary interventions
Twelve-month outcomes of 400 patients treated with a resorbable metal scaffold: insights from the BIOSOLVE-IV registry February 7, 2020 | 10.4244/EIJ-D-18-01058
Coronary interventions
Impact of clinical and hemodynamic factors on coronary flow reserve and invasive coronary flow capacity in non-obstructed coronary arteries - A patient level pooled analysis of the DEBATE and ILIAS studies January 21, 2020 | 10.4244/EIJ-D-19-00774
Coronary interventions
BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months December 6, 2019 | 10.4244/EIJ-D-18-01214
Evolving paradigms in valvular heart disease: where should guidelines move?
November 15, 2019 | 10.4244/EIJ-D-19-00818
Interventions for valvular disease
Coronary sinus to mitral valve annulus topography and response to the percutaneous coronary sinus-based mitral valve contour system November 15, 2019 | 10.4244/EIJ-D-19-00054
Coronary interventions
Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial September 10, 2019 | 10.4244/EIJ-D-19-00498
Will ORBITA change my practice? ORBITA trial: Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina
October 19, 2018 | 10.4244/EIJY18M09_2
Stents and scaffolds
Preclinical evaluation of degradation kinetics and elemental mapping of first- and second-generation bioresorbable magnesium scaffolds October 12, 2018 | 10.4244/EIJ-D-17-00708
Welcome to PCR London Valves 2018: 10th Anniversary Edition
September 7, 2018 | 10.4244/EIJV14SABA1
Other
Evaluating the importance of sham-controlled trials in the investigation of medical devices in interventional cardiology August 24, 2018 | 10.4244/EIJ-D-18-00481
EAPCI Presidential “criss-cross”
May 20, 2018 | 10.4244/EIJV14I1A7
May in Paris! Join us! EuroPCR 2018
April 20, 2018 | 10.4244/EIJV13I17A326
Stents and scaffolds
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial) January 19, 2018 | 10.4244/EIJ-D-17-00873
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary
January 19, 2018 | 10.4244/EIJ20170912-01
Answering the challenges of the New Year – the EAPCI in 2018
January 19, 2018 | 10.4244/EIJV13I13A243
The year of memories comes to an end, but the time of achievements continues
December 20, 2017 | 10.4244/EIJV13I11A201
Lesion preparation with cutting balloon angioplasty is associated with coronary aneurysm formation in polylactide bioresorbable vascular scaffold implantation
December 8, 2017 | 10.4244/EIJ-D-17-00375